Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial
Sophie Merrick, Annabelle South, Elena Frangou, Hannah L Rush, Grisma Patel, Jemima Thompson, Hannah Plant, Lisa Pickering · 2026
Read Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial by Sophie Merrick, Annabelle South, Elena Frangou, Hannah L Rush, Grisma Patel, Jemima Thompson, Hannah Plant, Lisa Pickering (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0358789.txt.
Description
Sophie Merrick leads a team of eight listening to kidney cancer patients who took immune therapy after surgery, in PLOS ONE in 2026. The interviews sit inside RAMPART, a large international trial testing whether checkpoint inhibitors after kidney removal can stop the cancer returning. Standard quality of life questionnaires predate this drug class. So the team interviewed twenty-three UK participants, chosen to span good and bad treatment experiences. They wanted to learn what the therapy actually does to a life.
Two themes organized their accounts. The first was living in a changed body and mind, as immune side effects altered energy, gut, and mood. The second was context: the same side effect landed differently depending on a person's work, family, and stage of life. How long effects lasted weighed heavily with participants. The study argues that trial measurement must catch duration and life context, not just symptom checklists.
Catalog record
| CREATOR | Sophie Merrick, Annabelle South, Elena Frangou, Hannah L Rush, Grisma Patel, Jemima Thompson, Hannah Plant, Lisa Pickering |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48402 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |